Newsletter | January 6, 2026

01.06.26 -- Why Efficiency In Multi-Modal CGT Manufacturing Is About Execution, Not Just Cost

FOCUS ON MANUFACTURING

Why Efficiency In Multi-Modal CGT Manufacturing Is About Execution, Not Just Cost

Our recent Cell & Gene Live, Driving Efficiency, Reducing Costs in Multi-Modal CGT Manufacturing, explored how developers and CDMOs are navigating multi-modal manufacturing decisions, balancing cost, capacity, risk, and long-term commercial viability.

Considerations For Cell Therapy Development And Manufacturing

Review the latest methodologies, common practices, resources, applications and more to support every step of your cell therapy manufacturing workflow.

An Efficient End-To-End AAV8 Platform Process

Explore a scalable AAV production platform that improves full capsid yield and dramatically reduces host cell impurities, offering a practical solution to common manufacturing challenges.

Quantifying Lentiviral Physical Titer

Streamline lentiviral vector analytics with our direct RT-dPCR method. Achieve precise, reproducible results to accelerate safe, effective gene therapies with enhanced quality control.

Practical Tips For Maintaining Healthy Cell Cultures

Humidity is a critical yet often overlooked factor in cell culture. Learn how it impacts cell viability and discover practical strategies to maintain optimal conditions for reliable results.

Assessing Particle Generation In A Single-Use Mixing System

See how particle levels remained stable during 24 hours of high-speed mixing, even under extreme temperatures, in this system for final fill and particulate-sensitive applications.

The Importance Of Scalability In Viral Vectors

Diseases that lack a cure, or even treatment, may be addressed with new gene therapeutic classes. This potential has spurred new investments in the drug development and commercialization space.

Design–Build Cleanroom Projects: A Proven Risk Mitigating Methodology

Building the right cleanroom involves critical early decisions. Uncover a methodical framework ensuring flexibility, compliance, and operational readiness from initial concept through delivery.

Make Your Production Sites Adaptable And More Efficient

Pharma faces mounting complexity and tighter margins, demanding agile, future-ready production. Discover how smart manufacturing enables faster adaptation and continuous therapy availability.

The Case For Modernizing Small-Volume Aseptic Processing

Tube welding and biosafety cabinets present significant costs and risks for small-volume aseptic processing. Modern single-use aseptic connectors offer a more efficient alternative.

Transient Expression Technologies For Antibody Production

Read these studies that showcase the potential of a system for CHO growth in early stage drug development, where high titer antibody production in suspension CHO cells is crucial.

SPONSOR

Simplified Harvest and Media Exchange in Cell Therapy: Consistent, Compliant Scale-Up from Development to GMP

Developing robust cell harvest and media exchange processes has become increasingly complex in GMP manufacturing. Variability from equipment, scale, and automation can delay timelines and impact product quality. In this webinar, CARR Biosystems shares case studies showing how low-shear, single-use centrifugation enables consistent harvest and media exchange across cell types while preserving CQAs. Click here to learn more.

MANUFACTURING SOLUTIONS

Mid Scale Plate-Based Freeze-Thaw Unit - Single Use Support

Generation Of Tumor-Reactive T Cells - Miltenyi Biotec

Stainless Steel Centrifuges For Cell And Gene Drug Manufacturing - CARR Biosystems

Customizable HEK Cell Culture Medium - Nucleus Biologics

A Gentler Elutriation System - Invetech

Connect With Cell & Gene: